NCT00756548View on ClinicalTrials.gov

BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

386

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

November 30, 2008

Conditions
Colon Cancer
Interventions
DRUG

BLI850

multi-dose preparation for oral administration prior to colonoscopy

DRUG

polyethylene glycol 3350 based bowel preparation

multi-dose preparation for oral administration prior to colonoscopy

Trial Locations (12)

22911

Charlottesville Medical Research, Charlottesville

37067

Franklin Gastroenterology, Franklin

37203

The Frist Clinic, Nashville

38138

Memphis Gastroenterology Group, Germantown

39202

Gastrointestinal Associates, Jackson

46202

Indiana University Medical Center, Indianapolis

74104

Options Health Research, Tulsa

77090

Houston Medical Research Associates, Houston

92801

Advanced Clinical Research Institute, Anaheim

92869

Advanced Clinical Research Institute, Orange

97210

Northwest Gastroenterology Clinic, Portland

98004

Northwest Gastroenterology Associates, Bellevue

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY